MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

Completed · Phase 2 · Has a placebo group

Conditions studied: Overactive Bladder

In brief

To evaluate the safety and efficacy of SSR240600C versus placebo on clinical and cystometric parameters in patients with OAB and UUI.

Key facts

Study ID
NCT00174798
Run by
Sanofi
People needed
118
Starts
2005-05-01
Expected to finish
2006-05-01
Last updated by the study team
2012-02-02

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.